In furtherance to letter dated January 20, 2025, regarding the Postal Ballot Notice wherein the Company had sought consent from the Members through remote e-voting on the following items of business: Appointment of Revati Parag Kasture (DIN: 07558973) as a Director (Non-Executive, Independent) of the Company and pursuant to Regulation 44(3) of Listing Regulations, Sequent Scientific has informed that the aforesaid resolution has been passed by the Members of the Company with requisite majority. The resolution is deemed to have been passed on the last date of the remote e-voting, Wednesday, February 19, 2025. The company has enclosed the Voting Results (‘Annexure A’) and Report of the Scrutinizer on remote e-voting in accordance with Rule 22 of the Companies (Management and Administration) Rules, 2014. A copy of the same is also being made available on the website of the Company at www.sequent.in.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1766.00 |
Dr. Reddys Lab | 1180.55 |
Cipla | 1510.65 |
Lupin | 2068.70 |
Zydus Lifesciences | 907.45 |
View more.. |